Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-Yuan Cheng

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|February 9, 2021
Targeting phospholipid metabolism for glioblastoma therapyTianzhi Huang, Shi-Yuan Cheng
Current Oncology Reports|February 17, 2009
Angiopoietin-2: development of inhibitors for cancer therapyBo Hu, Shi-Yuan Cheng
Neuro-Oncology|June 24, 2022
Targeting neddylation in cancerAnshika Goenka, Shi-Yuan Cheng
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
DNA damage and metabolic mechanisms of cancer drug resistanceDeanna Tiek, Shi-Yuan Cheng
Neuro-Oncology|January 11, 2022
New life for an old therapy: ELTD1 as a downstream target of angiogenesisDeanna Marie Tiek, Shi-Yuan Cheng
Chinese Journal of Cancer|September 2, 2011
Platelet-derived growth factor signaling in human malignanciesKun-Wei Liu, Bo Hu, Shi-Yuan Cheng
Chinese Journal of Cancer|September 2, 2011
Platelet-derived growth factor receptor alpha in glioma: a bad seedKun-Wei Liu, Bo Hu, Shi-Yuan Cheng
Chinese Journal of Cancer|November 12, 2013
Noncoding RNAs in cancer and cancer stem cellsTianzhi Huang, Angel Alvarez, Bo Hu, et al.
Bio-Protocol|June 29, 2026
Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq DataMaya N Walker, Bo Hu, Shi-Yuan Cheng, et al.
Genomics|June 19, 2004
Identification of two novel alternatively spliced Neuropilin-1 isoformsFrank C Cackowski, Li Xu, Bo Hu, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|February 9, 2021
Targeting phospholipid metabolism for glioblastoma therapyTianzhi Huang, Shi-Yuan Cheng
Current Oncology Reports|February 17, 2009
Angiopoietin-2: development of inhibitors for cancer therapyBo Hu, Shi-Yuan Cheng
Neuro-Oncology|June 24, 2022
Targeting neddylation in cancerAnshika Goenka, Shi-Yuan Cheng
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
DNA damage and metabolic mechanisms of cancer drug resistanceDeanna Tiek, Shi-Yuan Cheng
Neuro-Oncology|January 11, 2022
New life for an old therapy: ELTD1 as a downstream target of angiogenesisDeanna Marie Tiek, Shi-Yuan Cheng
Chinese Journal of Cancer|September 2, 2011
Platelet-derived growth factor signaling in human malignanciesKun-Wei Liu, Bo Hu, Shi-Yuan Cheng
Chinese Journal of Cancer|September 2, 2011
Platelet-derived growth factor receptor alpha in glioma: a bad seedKun-Wei Liu, Bo Hu, Shi-Yuan Cheng
Chinese Journal of Cancer|November 12, 2013
Noncoding RNAs in cancer and cancer stem cellsTianzhi Huang, Angel Alvarez, Bo Hu, et al.
Bio-Protocol|June 29, 2026
Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq DataMaya N Walker, Bo Hu, Shi-Yuan Cheng, et al.
Genomics|June 19, 2004
Identification of two novel alternatively spliced Neuropilin-1 isoformsFrank C Cackowski, Li Xu, Bo Hu, et al.
Pageof 13